Cargando…

Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct characteristics and prognoses. Although cytogenetic changes and gene mutations are associated with AML prognosis, there is a need to identify further factors. CD56 is considered a prognostic factor for AML, which is abn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yanni, Wan, Jia, Song, Qiuyue, Luo, Chengxin, Li, Xi, Luo, Yanrong, Huang, Xiangtao, Ding, Ruiheng, Li, Hui, Hou, Yu, Huang, Yongxiu, Xie, Mingling, Huang, Zhen, Zhang, Yali, Ma, Yanni, Wu, Guixian, Xu, Shuangnian, Chen, Jieping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049794/ https://www.ncbi.nlm.nih.gov/pubmed/33928145 http://dx.doi.org/10.1155/2021/1929357

Ejemplares similares

Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20(+) B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis
por: Luo, Chengxin, et al.
Publicado: (2021)

Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation
por: Luo, Chengxin, et al.
Publicado: (2021)

Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies
por: Luo, Chengxin, et al.
Publicado: (2021)

SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression
por: Zhang, Yali, et al.
Publicado: (2021)

Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials
por: Luo, Chengxin, et al.
Publicado: (2022)

Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials
por: Luo, Chengxin, et al.
Publicado: (2023)

Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis
por: Xu, Shuangnian, et al.
Publicado: (2015)

Genetic polymorphisms of NAT2 and risk of acute myeloid leukemia: A case-control study
por: Zou, Yunding, et al.
Publicado: (2017)

High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials
por: Gong, Qiang, et al.
Publicado: (2015)

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
por: Liang, Tianqi, et al.
Publicado: (2022)

First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review
por: Fu, Weijia, et al.
Publicado: (2021)

The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Alegretti, Ana Paula, et al.
Publicado: (2011)

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011)

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia
por: Zhang, Lidan, et al.
Publicado: (2013)

Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis
por: Hu, Xiaoye, et al.
Publicado: (2018)

Downregulated stromal antigen 2 expression in de novo acute myeloid leukemia patients
por: Han, Qiaoyan, et al.
Publicado: (2017)

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia
por: Hu, Xuelian, et al.
Publicado: (2020)

Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis
por: Jiang, Xiuxing, et al.
Publicado: (2022)

The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients
por: Pasca, Sergiu, et al.
Publicado: (2020)

Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia
por: Aref, Salah, et al.
Publicado: (2020)

Decoding the Mechanism of Shen Qi Sha Bai Decoction in Treating Acute Myeloid Leukemia Based on Network Pharmacology and Molecular Docking
por: Jia, Guanfei, et al.
Publicado: (2021)

High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia
por: Zheng, Yongzhi, et al.
Publicado: (2021)

De novo acute myeloid leukemia with monocytoid blasts and erythrophagocytosis
por: Blieden, Clifford, et al.
Publicado: (2014)

SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia
por: Dong, Song, et al.
Publicado: (2015)

GCT-56. ACUTE MYELOID LEUKEMIA FOLLOWING CHEMORADIOTHERAPY FOR INTRACRANIAL GERMINOMA: A CASE REPORT
por: Nakaya, Masato, et al.
Publicado: (2020)

Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells
por: Hu, Yanni, et al.
Publicado: (2010)

Cytogenetic Profile of de novo Acute Myeloid Leukemia Patients in Malaysia
por: Meng, Chin Yuet, et al.
Publicado: (2013)

Cytogenetic Characteristics of de novo Acute Myeloid Leukemia in Southern Vietnam
por: Thao, Lai Thi Thanh, et al.
Publicado: (2023)

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
por: Hou, Hsin-An, et al.
Publicado: (2016)

New insights into antigen specific immunotherapy for chronic myeloid leukemia
por: Li, Yangqiu, et al.
Publicado: (2012)

TAF1 inhibitor Bay-299 induces cell death in acute myeloid leukemia
por: Zhou, Lixin, et al.
Publicado: (2021)

A Cdh1–FoxM1–Apc axis controls muscle development and regeneration
por: Chen, Zhe, et al.
Publicado: (2020)

Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia
por: Zhang, Yujiao, et al.
Publicado: (2023)

Clinical characterization and prognosis of T cell acute lymphoblastic leukemia with high CRLF2 gene expression in children
por: Wang, Mingmin, et al.
Publicado: (2019)

Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021)

Characterizing the Molecular Abnormalities in Rare De Novo Ph(+) Acute Myeloid Leukemia
por: Chao, Hong-Ying, et al.
Publicado: (2018)

Recent advance in phytonanomedicine and mineral nanomedicine delivery system of the treatment for acute myeloid leukemia
por: Jia, Yimin, et al.
Publicado: (2023)

New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells
por: Liu, Yanni, et al.
Publicado: (2022)

Favorable clinical outcome and unique characteristics in association with Twist1 overexpression in de novo acute myeloid leukemia
por: Chen, C-C, et al.
Publicado: (2015)

Exercise protects proliferative muscle satellite cells against exhaustion via the Igfbp7-Akt-mTOR axis
por: Chen, Zhe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ke5a9sjlhfhgpibmaqijv7p1un